Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin.

Mantovani, L

Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin. [electronic resource] - British journal of haematology May 2000 - 367-75 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article

0007-1048

10.1046/j.1365-2141.2000.02016.x doi


Adult
Aged
Aged, 80 and over
Anemia--blood
Disease-Free Survival
Drug Administration Schedule
Drug Therapy, Combination
Erythrocyte Count
Erythropoietin--administration & dosage
Female
Granulocyte Colony-Stimulating Factor--administration & dosage
Humans
Male
Middle Aged
Myelodysplastic Syndromes--blood
Recombinant Proteins
Time Factors
Treatment Outcome